Accéder au contenu
Merck

204463

Strontium chloride hexahydrate

99.995% trace metals basis

Synonyme(s) :

Strontium dichloride hexahydrate

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Toutes les photos(3)

About This Item

Formule linéaire :
SrCl2 · 6H2O
Numéro CAS:
10025-70-4
Poids moléculaire :
266.62
NACRES:
NA.23
PubChem Substance ID:
24852271
UNSPSC Code:
12352302
EC Number:
233-971-6
MDL number:
MFCD00149865
assay:
99.995% trace metals basis
form:
powder and chunks
solubility:
ethanol: slightly soluble(lit.)

Nom du produit

Strontium chloride hexahydrate, 99.995% trace metals basis

InChI key

AMGRXJSJSONEEG-UHFFFAOYSA-L

InChI

1S/2ClH.6H2O.Sr/h2*1H;6*1H2;/q;;;;;;;;+2/p-2

SMILES string

O.O.O.O.O.O.Cl[Sr]Cl

assay

99.995% trace metals basis

form

powder and chunks

reaction suitability

core: strontium

impurities

≤55.0 ppm Trace Metal Analysis

mp

115 °C (lit.)

solubility

ethanol: slightly soluble(lit.)

Quality Level

100

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Application

  • Development of novel composite PCM for thermal energy storage using CaCl2· 6H2O with graphene oxide and SrCl2· 6H2O: This study details the development of a new composite phase change material incorporating strontium chloride hexahydrate, relevant for material scientists focused on energy storage solutions (Xu et al., 2017).
  • Toxicity assessment of artificially added zinc, selenium, and strontium in water: This research assesses the toxicity of strontium chloride hexahydrate in aquatic environments, which is crucial for environmental chemists and toxicologists studying the impact of chemical agents on aquatic life (Liu et al., 2019).

pictograms

Corrosion
GHS05

signalword

Danger

hcodes

H318

Hazard Classifications

Eye Dam. 1

Classe de stockage

13 - Non Combustible Solids

wgk

WGK 1

ppe

dust mask type N95 (US), Eyeshields, Gloves

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number
0000430685
0000430685
0000426330
0000426330
0000350478

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Salil Vengalil et al.
Current opinion in supportive and palliative care, 6(3), 310-315 (2012-06-20)
Bone metastases in prostate cancer are often the cause of significant morbidity in patients with castrate-resistant disease, and several studies have shown significant pain palliation with systemic radionuclide treatment. The purpose of this review is to discuss the place of
Rui Li et al.
American journal of dentistry, 25(4), 210-214 (2012-10-23)
To investigate the laboratory changes in dentin tubule occlusion morphology during short term use of desensitizing products as evaluated by electron microscopy and an image analysis. Freshly extracted human third molar teeth were collected at random and 40 dentin discs
Serdal Kirmizialtin et al.
Biophysical journal, 102(4), 829-838 (2012-03-06)
The distributions of different cations around A-RNA are computed by Poisson-Boltzmann (PB) equation and replica exchange molecular dynamics (MD). Both the nonlinear PB and size-modified PB theories are considered. The number of ions bound to A-RNA, which can be measured
Diane Cummins
American journal of dentistry, 23 Spec No A, 3A-13A (2011-02-03)
To provide a brief overview of the diagnosis, epidemiology, etiology and clinical management of dentin hypersensitivity, to discuss technical approaches to relieve sensitivity, with special emphasis on dentin tubule occlusion and the clinical evidence for efficacy of desensitizing toothpastes based
Karen A Autio et al.
Current treatment options in oncology, 13(2), 174-188 (2012-04-25)
Skeletal metastases threaten quality of life, functionality, and longevity in patients with metastatic castration-resistant prostate cancer (mCRPC). Therapeutic strategies for bone metastases in prostate cancer can palliate pain, delay/prevent skeletal complications, and prolong survival. Pharmacologic agents representing several drug classes
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique